PRESS RELEASE published on 07/01/2026 at 14:51, 2 months 24 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital according to French regulations. Total shares: 97,330,405. Total voting rights: 164,770,927 Voting Rights Capital Shares French Regulations Sartorius Stedim Biotech
PRESS RELEASE published on 07/01/2026 at 14:51, 2 months 24 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Sartorius Stedim Biotech SA déclare le nombre d'actions et de droits de vote composant son capital social. Informations réglementaires transmises par EQS Group Déclaration Nombre D'actions Droits De Vote Capital Social Sartorius Stedim Biotech
PRESS RELEASE published on 07/01/2026 at 14:45, 2 months 24 days ago Games of the Future 2026 Confirms Global Lineup for Astana Games of the Future 2026 confirms the final lineup of clubs and athletes set to compete at the world's leading phygital sporting event in Astana, featuring elite esports and sporting competition across eight disciplines with over US$4 million in prize money Esports Phygital Sport Games Of The Future 2026 Astana Global Lineup
PRESS RELEASE published on 07/01/2026 at 14:41, 2 months 24 days ago Viridien : Informations relatives au nombre total de droits de vote et d'actions Viridien communique les informations relatives au nombre total de droits de vote et d'actions conformément aux réglementations en vigueur Droits De Vote Actions Informations Réglementations Viridien
PRESS RELEASE published on 07/01/2026 at 14:40, 2 months 24 days ago Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares Abivax prices highly oversubscribed $800M public offering of American Depositary Shares, with increased gross proceeds expected to support commercialization efforts and clinical development Abivax Clinical Development Commercialization Public Offering American Depositary Shares
PRESS RELEASE published on 07/01/2026 at 14:39, 2 months 24 days ago Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares Abivax annonce la fixation du prix de l’Offre au public de 800 M$ (702 M€) d’American Depositary Shares. Montant augmenté à 800 M$ avec un prix de 125,00 $ par ADS, prolongeant l’horizon de trésorerie jusqu’au deuxième trimestre 2029 Abivax Trésorerie Dilution American Depositary Shares Prix De L'offre
PRESS RELEASE published on 07/01/2026 at 14:30, 2 months 24 days ago #LUXMyWill: Beauty Brand LUX Turns '#BuryMeInThis' From Social Media Trend Into Legal Declaration Global beauty brand LUX partners with VML Singapore to launch #LUXMyWill, transforming social media beauty trends into lasting personal style declarations LUX VML Singapore Beauty Trend Personal Style #LUXMyWill
PRESS RELEASE published on 07/01/2026 at 14:30, 2 months 24 days ago AIAI Holdings' MediGuide Launches Digital Platform Ai2's portfolio company, MediGuide International, launches a new digital platform to enhance healthcare services worldwide through Transformational AI. A step towards innovation in diagnostics and precision medicine Digital Platform Healthcare Innovation Transformational AI Ai2 MediGuide International
PRESS RELEASE published on 07/01/2026 at 13:57, 2 months 24 days ago Amundi Physical Metals plc: UK Final Terms Amundi Physical Metals plc issues 130,000.00 ETC Securities of Amundi Physical Gold ETC under its Secured Precious Metal Linked ETC Securities Programme. Final Terms dated 30 June 2026 Gold ETC Amundi Physical Metals Plc ETC Securities Precious Metal Final Terms
PRESS RELEASE published on 07/01/2026 at 13:55, 2 months 24 days ago AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans AdJane reports first clinical validation of its OMV vaccine platform inducing mucosal immunity in humans. Study demonstrates intranasal OMV-based vaccination's ability to trigger systemic and mucosal immune responses Respiratory Infections Pandemic Preparedness AdJane Mucosal Immunity OMV Vaccine Platform
Published on 09/26/2026 at 01:00, 56 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 3 hours 41 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 8 hours 26 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 10 hours 56 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 00:01, 1 hour 55 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 7 hours 26 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 7 hours 56 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 8 hours 26 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)
Published on 09/25/2026 at 17:45, 8 hours 11 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 8 hours 16 minutes ago Availability of the 2026 half-year financial report
Published on 09/25/2026 at 17:40, 8 hours 16 minutes ago Mise à disposition du rapport financier semestriel 2026